Olema Pharmaceuticals, Inc. (23)
Browse by Contract Category
Contracts
-
Description of Capital Stock
(Filed With SEC on March 17, 2021)
-
Olema Pharmaceuticals, Inc. 2020 Equity Incentive Plan
(Filed With SEC on November 16, 2020)
-
Amended and Restated Offer Letter by and between the Registrant and John B. Moriarty, Jr., dated November 13, 2020
(Filed With SEC on November 16, 2020)
-
Clinical Collaboration and Supply Agreement by and between the Registrant and Novartis Institutes for BioMedical Research, Inc., dated July 22, 2020
(Filed With SEC on October 30, 2020)
-
Amended and Restated Offer Letter by and between the Registrant and David Myles, dated November 13, 2020
(Filed With SEC on November 16, 2020)
-
Amended and Restated Offer Letter by and between the Registrant and Peter Kushner, dated November 13, 2020
(Filed With SEC on November 16, 2020)
-
Amended and Restated Offer Letter by and between the Registrant and Shane Kovacs, dated November 13, 2020
(Filed With SEC on November 16, 2020)
-
Amended and Restated Offer Letter by and between the Registrant and Kinney Horn, dated November 13, 2020
(Filed With SEC on November 16, 2020)
-
Amended and Restated Offer Letter by and between the Registrant and Cyrus L. Harmon, dated November 13, 2020
(Filed With SEC on November 16, 2020)
-
Amended and Restated Offer Letter by and between the Registrant and Sean Bohen, dated November 13, 2020
(Filed With SEC on November 16, 2020)
-
Olema Pharmaceuticals, Inc. 2020 Non-Employee Director Compensation Policy
(Filed With SEC on November 16, 2020)
-
Olema Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan
(Filed With SEC on November 16, 2020)
-
Form of Common Stock Certificate
(Filed With SEC on November 16, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on November 16, 2020)
-
Olema Pharmaceuticals, Inc. 2014 Stock Plan, as amended
(Filed With SEC on October 30, 2020)
-
Form of Indemnification Agreement by and between the Registrant and its directors and executive officers
(Filed With SEC on October 30, 2020)
-
Olema Pharmaceuticals, Inc. 2020 Non-Employee Director Compensation Policy
(Filed With SEC on October 30, 2020)
-
Olema Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan
(Filed With SEC on October 30, 2020)
-
Forms of Restricted Stock Unit Grant Notice and Award Agreement under the Olema Pharmaceuticals, Inc. 2020 Equity Incentive Plan
(Filed With SEC on October 30, 2020)
-
Forms of Stock Option Grant Notice and Stock Option Agreement under the Olema Pharmaceuticals, Inc. 2020 Equity Incentive Plan
(Filed With SEC on October 30, 2020)
-
Olema Pharmaceuticals, Inc. 2020 Equity Incentive Plan
(Filed With SEC on October 30, 2020)
-
Forms of Stock Option Grant Notice, Stock Option Agreement, Early Exercise Stock Purchase Agreement and Notice of Exercise and Restricted Stock Award Grant Notice and Restricted...
(Filed With SEC on October 30, 2020)
-
Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated September 30, 2020
(Filed With SEC on October 30, 2020)